Bulk Manufacturer of Controlled Substances Application: Rhodes Technologies, 34371-34372 [2016-12752]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 104 / Tuesday, May 31, 2016 / Notices
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–952]
Certain Electronic Devices, Including
Wireless Communication Devices,
Computers, Tablet Computers, Digital
Media Players, and Cameras;
Commission Determination to Affirm
an Initial Determination Granting a
Joint Motion to Terminate the
Investigation on the Basis of
Settlement; Termination of
Investigation
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that
the U.S. International Trade
Commission has determined to affirm
the administrative law judge’s (ALJ)
initial determination (ID) (Order No. 52)
granting a joint motion to terminate the
above-referenced investigation on the
basis of a settlement agreement.
FOR FURTHER INFORMATION CONTACT: Ron
Traud, Office of the General Counsel,
U.S. International Trade Commission,
500 E Street SW., Washington, DC
20436, (202) 205–3427. Copies of nonconfidential documents filed in
connection with this investigation are or
will be available for inspection during
official business hours (8:45 a.m. to 5:15
p.m.) in the Office of the Secretary, U.S.
International Trade Commission, 500 E
Street SW., Washington, DC 20436,
(202) 205–2000. General information
concerning the Commission may also be
obtained by accessing its Internet server
at https://www.usitc.gov. The public
record for this investigation may be
viewed on the Commission’s electronic
docket (EDIS) at https://edis.usitc.gov.
Hearing-impaired persons are advised
that information on this matter can be
obtained by contacting the
Commission’s TDD terminal on (202)
205–1810.
SUPPLEMENTARY INFORMATION: On April
3, 2015, the Commission instituted this
investigation (the 952 investigation)
based on a complaint filed by Ericsson
Inc. of Plano, Texas and
Telefonaktiebolaget LM Ericsson of
Sweden (collectively, ‘‘Ericsson’’). 80
FR 18254 (Apr. 3, 2015). The complaint
alleged violations of 19 U.S.C. 1337
(Section 337) based upon the
importation into the United States, the
sale for importation, and the sale within
the United States after importation of
certain electronic devices, including
wireless communication devices,
computers, tablet computers, digital
media players, and cameras by reason of
sradovich on DSK3TPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
20:07 May 27, 2016
Jkt 238001
infringement of certain claims of U.S.
Patent Nos. 6,633,550; 6,157,620;
6,029,052; 8,812,059; 6,291,966; and
6,122,263. Id. at 18255. The
Commission’s Notice of Investigation
named Apple Inc. of Cupertino,
California (Apple) as respondent and
also named the Office of Unfair Import
Investigations (OUII) as a party. Id.
On December 29, 2015, Ericsson and
Apple (collectively, the private parties)
filed a joint motion to terminate the
investigation pursuant to Commission
Rule 210.21(b) on the basis of a
settlement. See Order No. 51 at 1 (Jan.
12, 2016). On January 12, the ALJ (Judge
Shaw) denied the motion because the
private parties failed to provide a copy
of the Agreement. See id. On February
1, 2016, the private parties filed a
second amended joint motion (the Joint
Motion) to terminate the investigation in
view of a settlement agreement. See
Order 52 at 1 (Mar. 9, 2016) [hereinafter,
the Subject ID]. The motion included
both a confidential, un-redacted and a
public, redacted copy of the settlement
agreement (the Agreement). Id. at 2. The
Agreement and a corresponding motion
to terminate were also filed in
Investigation No. 337–TA–953 (the 953
investigation). Id.
On February 3, 2016, the ALJ
presiding in the 953 investigation (Judge
Lord) denied the motion to terminate
that investigation, reasoning that the
public version of the Agreement was
over-redacted. See id. Pursuant to
Commission Rules 210.24(b)(2)–(3) and
210.5(e), Ericsson filed a petition for
interlocutory Commission review of
only five of Judge Lord’s confidentiality
determinations. See Complainant
Ericsson’s Application for Commission
Review of Certain Confidentiality
Determinations in Order No. 45 (Feb.
11, 2016). Ericsson submitted with its
appeal a revised, less-redacted public
version of the Agreement (the Final
Public Version). Id.
On March 9, 2016, Judge Shaw issued
the Subject ID, which grants the Joint
Motion. Subject ID, at 3. The Subject ID
concludes that termination of the 952
investigation based on the private
parties’ settlement is in the public
interest. Id. at 2. The Subject ID then
declares that the private parties should
file another public version of the
Agreement in accordance with Judge
Lord’s ruling in the 953 investigation, as
affirmed or modified by the
Commission. See id. at 2–3. No petitions
for review of the Subject ID were filed.
On April 8, 2016, the Commission
determined to review the Subject ID.
Notice of Commission Determination to
Review an Initial Determination
Granting a Joint Motion to Terminate
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
34371
the Investigation on the Basis of
Settlement, at 2 (Apr. 8, 2016).
On May 4, 2016, the Commission
granted Ericsson’s interlocutory appeal
in the 953 investigation, reversed the
ALJ on all five of the appealed
confidentiality determinations, and
remanded to the ALJ. Order Granting
Appeal for Interlocutory Review of
Order No. 45, Upon Review, Reversing,
and Remanding to the Administrative
Law Judge, at 3 (May 4, 2016).
On May 9, 2016, Ericsson filed with
the Commission for purposes of the 952
investigation the Final Public Version.
Letter to Secretary Lisa R. Barton
enclosing Proposed Public Version of
Parties’ Global Patent License
Agreement for Consideration in the
Pending Initial Determination
Terminating the Investigation Based on
a Settlement Agreement (May 9, 2016).
The Commission hereby affirms the
Subject ID, which grants the private
parties’ motion to terminate the
investigation.
The authority for the Commission’s
determination is contained in Section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in Part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: May 25, 2016.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2016–12711 Filed 5–27–16; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Rhodes
Technologies
Drug Enforcement
Administration, DOJ.
ACTION: Notice of application.
AGENCY:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before August 1, 2016.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION:
DATES:
E:\FR\FM\31MYN1.SGM
31MYN1
34372
Federal Register / Vol. 81, No. 104 / Tuesday, May 31, 2016 / Notices
The Attorney General has delegated
her authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on March
26, 2016, Rhodes Technologies, 498
Washington Street, Coventry, Rhode
Island 02816 applied to be registered as
a bulk manufacturer the following basic
classes of controlled substances:
Controlled substance
Schedule
Tetrahydrocannabinols (7370) .....
Dihydromorphine (9145) ...............
Methylphenidate (1724) ................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Levorphanol (9220) ......................
Morphine (9300) ...........................
Oripavine (9330) ...........................
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Tapentadol (9780) ........................
Fentanyl (9801) ............................
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for conversion and sale to dosage form
manufacturers.
In reference to drug code 7370 the
company plans to bulk manufacture a
synthetic tetrahydrocannabinol. No
other activity for this drug code is
authorized for this registration.
sradovich on DSK3TPTVN1PROD with NOTICES
Dated: May 19, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–12752 Filed 5–27–16; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
20:07 May 27, 2016
Jkt 238001
of the following basic classes of
controlled substances:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Controlled substance
[Docket No. DEA–392]
Schedule
Importer of Controlled Substances
Application: Wildlife Laboratories, Inc.
Etorphine (except HCl) (9056) ..........
Etorphine HCl (9059) ........................
Drug Enforcement
Administration, DOJ.
ACTION: Notice of application.
The company plans to import the
listed controlled substances for sale to
its customer.
AGENCY:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before June 30, 2016. Such persons
may also file a written request for a
hearing on the application pursuant to
21 CFR 1301.43 on or before June 30,
2016.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/ODW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on
February 19, 2016, Wildlife
Laboratories, Inc., 1230 W. Ash Street,
Suite D, Windsor, Colorado 80550–8055
applied to be registered as an importer
ADDRESSES:
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
I
II
Dated: May 19, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–12751 Filed 5–27–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Office of the Secretary
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Trade
Adjustment Assistance Program
Reserve Funding Request
ACTION:
Notice.
The Department of Labor
(DOL) is submitting the Employment
and Training Administration (ETA)
sponsored information collection
request (ICR) titled, ‘‘Trade Adjustment
Assistance Program Reserve Funding
Request,’’ to the Office of Management
and Budget (OMB) for review and
approval for continued use, without
change, in accordance with the
Paperwork Reduction Act of 1995
(PRA), 44 U.S.C. 3501 et seq. Public
comments on the ICR are invited.
DATES: The OMB will consider all
written comments that agency receives
on or before June 30, 2016.
ADDRESSES: A copy of this ICR with
applicable supporting documentation;
including a description of the likely
respondents, proposed frequency of
response, and estimated total burden
may be obtained free of charge from the
RegInfo.gov Web site at https://
www.reginfo.gov/public/do/
PRAViewICR?ref_nbr=201605-1205-009
(this link will only become active on the
day following publication of this notice)
or by contacting Michel Smyth by
telephone at 202–693–4129, TTY 202–
693–8064, (these are not toll-free
numbers) or by email at DOL_PRA_
PUBLIC@dol.gov.
Submit comments about this request
by mail or courier to the Office of
Information and Regulatory Affairs,
Attn: OMB Desk Officer for DOL–ETA,
Office of Management and Budget,
Room 10235, 725 17th Street NW.,
SUMMARY:
E:\FR\FM\31MYN1.SGM
31MYN1
]]>Agencies
[Federal Register Volume 81, Number 104 (Tuesday, May 31, 2016)]
[Notices]
[Pages 34371-34372]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-12752]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Rhodes
Technologies
AGENCY: Drug Enforcement Administration, DOJ.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before August 1, 2016.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
[[Page 34372]]
The Attorney General has delegated her authority under the
Controlled Substances Act to the Administrator of the Drug Enforcement
Administration (DEA), 28 CFR 0.100(b). Authority to exercise all
necessary functions with respect to the promulgation and implementation
of 21 CFR part 1301, incident to the registration of manufacturers,
distributors, dispensers, importers, and exporters of controlled
substances (other than final orders in connection with suspension,
denial, or revocation of registration) has been redelegated to the
Deputy Assistant Administrator of the DEA Office of Diversion Control
(``Deputy Assistant Administrator'') pursuant to section 7 of 28 CFR
part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on March
26, 2016, Rhodes Technologies, 498 Washington Street, Coventry, Rhode
Island 02816 applied to be registered as a bulk manufacturer the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)............... I
Dihydromorphine (9145)..................... I
Methylphenidate (1724)..................... II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Levorphanol (9220)......................... II
Morphine (9300)............................ II
Oripavine (9330)........................... II
Oxymorphone (9652)......................... II
Noroxymorphone (9668)...................... II
Tapentadol (9780).......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for conversion and sale to dosage form manufacturers.
In reference to drug code 7370 the company plans to bulk
manufacture a synthetic tetrahydrocannabinol. No other activity for
this drug code is authorized for this registration.
Dated: May 19, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-12752 Filed 5-27-16; 8:45 am]
BILLING CODE 4410-09-P
